Toronto Dominion Bank
EPZM

Toronto Dominion Bank’s Epizyme, Inc EPZM Stock Holding History

Toronto Dominion Bank’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-213,121
Closed -$533K – 2213
2021
Q4 		$533K Buy
+213,121
New +$837K ﹤0.01% 1178
2020
Q2 		– Sell
-102
Closed -$2K – 1415
2020
Q1 		$2K Hold
102
– – ﹤0.01% 1177
2019
Q4 		$3K Buy
102
+90
+750% +$1.34K ﹤0.01% 1269
2019
Q3 		$0 Sell
12
-18
-60% -$227 ﹤0.01% 1744
2019
Q2 		$0 Buy
+30
New +$386 ﹤0.01% 1840

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Toronto Dominion Bank's EPZM Position: Q1 2022 in Review

Toronto Dominion Bank sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 213,121 shares — an estimated $533K sold.

Toronto Dominion Bank first reported a position in EPZM in Q2 2019 and held it in 5 quarters. The position peaked at $533K in Q4 2021. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

  • Toronto Dominion Bank reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 213,121 Epizyme, Inc shares in Q1 2022, an estimated $533K.
  • Toronto Dominion Bank first reported a position in Epizyme, Inc in Q2 2019 and held it in 5 quarters.
  • Toronto Dominion Bank's Epizyme, Inc position peaked at $533K in Q4 2021.
  • 120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on Toronto Dominion Bank's 13F filing for Q1 2022, filed 9 May 2022.